| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 250.91B | 243.05B | 225.87B | 236.33B | 229.51B | 214.07B |
| Gross Profit | 35.80B | 34.68B | 32.35B | 32.07B | 37.23B | 32.01B |
| EBITDA | 8.06B | 7.30B | 7.65B | 7.10B | 9.44B | 5.99B |
| Net Income | 3.17B | 2.87B | 4.20B | 3.78B | 4.48B | 2.02B |
Balance Sheet | ||||||
| Total Assets | 170.32B | 171.04B | 161.31B | 156.72B | 157.92B | 143.87B |
| Cash, Cash Equivalents and Short-Term Investments | 24.67B | 30.07B | 41.77B | 37.42B | 33.11B | 27.83B |
| Total Debt | 46.41B | 41.99B | 40.97B | 46.64B | 52.08B | 51.38B |
| Total Liabilities | 108.82B | 109.37B | 104.33B | 105.33B | 109.38B | 104.71B |
| Stockholders Equity | 56.03B | 56.23B | 52.98B | 48.00B | 45.41B | 36.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.04B | 6.92B | 10.50B | 171.00M | 14.12B |
| Operating Cash Flow | 0.00 | -4.93B | 10.10B | 12.96B | 1.73B | 15.83B |
| Investing Cash Flow | 0.00 | -7.52B | 614.00M | -2.34B | -675.00M | -623.00M |
| Financing Cash Flow | 0.00 | 45.00M | -6.62B | -5.98B | 4.28B | -6.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥37.81B | 8.57 | ― | 1.78% | -0.94% | 51.59% | |
78 Outperform | ¥48.00B | 5.27 | ― | 3.87% | 2.66% | -11.41% | |
73 Outperform | ¥53.65B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
67 Neutral | ¥24.96B | 5.97 | ― | 3.55% | 12.31% | 90.88% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.23B | 15.26 | ― | 3.17% | 5.95% | 23.97% | |
61 Neutral | ¥159.65B | 9.98 | ― | 2.42% | 9.74% | 6.48% |